|
CHI's Discovery on Target invites accredited media working for scientific news organizations to register for a complimentary press pass. This premier event for target discovery and target validation strategies will provide members of the media access to four information packed days, including over 100 speakers. In addition to affording you access to these high quality talks this event will include an exhibit hall comprised of over 20 booths providing another great way to maximize your participation.
Press passes are limited, and are granted only to working journalists who intend to cover the event.
To qualify for press credentials, you must be affiliated with an internationally, nationally or regionally recognized media outlet, and hold an editorial title and or hold a position as an industry analyst. For more information on acceptable forms of credentials, please visit our
Frequently Asked Question Page or contact Tracey Fielding at
tfielding@healthtech.com
Personnel that are in sales, advertising, marketing, account management, or other non-editorial professions will not be granted a press or analyst pass. (CHI reserves the right to request documentation regarding credentials.)
Need more information? Visit our
Frequently Asked Question Page
Please email a copy of your completed article, along with the anticipated publish date to Tracey Fielding at
tfielding@healthtech.com
Click here to register for the upcoming Discovery on Target Conference.
Media and Press Contact:
If you have any questions regarding press access or wish to become a media partner for the event contact:
Tracey Fielding
Phone: 781-972-5429
Email: tfielding@healthtech.com
Please fill out the following information before you submit the form.
(all fields required)
Please select which programs you will be attending:
Pre-Conference Short Courses: (October 15)
SC1: RNAi for Beginners
SC2: miRNA Profi ling & Functional Screening
SC3: The Challenge of the Blood-Brain Barrier
SC4: Navigating the Bend Using Short Hairpin RNAs
Main Conference: (October 16 – 18)
RNAi FOR DRUG DISCOVERY & THERAPEUTICS
KINASE INHIBITORS
HDAC INHIBITORS
|